Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| CDP-Choline (Citicoline) | Coluracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 250-500 mg/day | 20-80 mg/day divided into 2-3 doses |
| Timing | Morning or split morning/afternoon. With or without food. | Morning and early afternoon. Sublingual administration may provide faster onset. With or without food. |
| Cycle Duration | Ongoing; no cycling required | Cycles of 4-8 weeks on, 2-4 weeks off |
| Evidence Level | strong_human | animal_plus_anecdotal |
Prodrug that is hydrolyzed to choline and cytidine upon oral ingestion. Choline supports acetylcholine synthesis and phosphatidylcholine membrane repair. Cytidine is converted to uridine, which enhances synaptic membrane synthesis via the Kennedy pathway and upregulates dopamine receptor density. This dual mechanism — cholinergic support plus dopaminergic modulation — is unique among choline sources.
250-500 mg/day
Morning or split morning/afternoon. With or without food.
Ongoing; no cycling required
Enhances high-affinity choline uptake (HACU) via a unique mechanism distinct from other racetams — it increases HACU even in damaged cholinergic neurons, suggesting a choline uptake enhancement rather than mere stimulation. This HACU enhancement persists even after the compound has been cleared, indicating a lasting modification of choline transporter activity. Also shows affinity for AMPA receptors.
20-80 mg/day divided into 2-3 doses
Morning and early afternoon. Sublingual administration may provide faster onset. With or without food.
Cycles of 4-8 weeks on, 2-4 weeks off
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →